Alignment Healthcare ( (ALHC) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Alignment Healthcare’s stock movement is influenced by its strong performance in medical expense management and operational efficiency. Analysts from Leerink Partners and TD Cowen have maintained their Buy ratings with a price target of $17, citing a 59% increase in Medicare Advantage membership and a promising clinical care model. The company’s projected adjusted EBITDA for 2025 is expected to surpass consensus expectations, driven by effective cost management and strategic changes. This positions Alignment Healthcare for margin expansion and growth, reinforcing confidence in its future performance.
More about Alignment Healthcare
YTD Price Performance: 35.73%
Average Trading Volume: 1,814,119
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $3.01B
For further insights into ALHC stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.